Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, cytologically malignant ameloblastoma that may metastasize.
Biomarker and diagnostic research for ameloblastic carcinoma has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for ameloblastic carcinoma.
49 publications have been identified in PubMed for ameloblastic carcinoma. Research spans Case Report / Case Series (35%), Review / Meta-Analysis (29%), and Epidemiology / Natural History (20%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 17 | 35% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:43 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
14 |
29% |
Disease patterns and progression | 10 | 20% |
Other research | 3 | 6% |
Laboratory research | 3 | 6% |
Testing and diagnosis research | 2 | 4% |
Okechi UC (2026). [PMID: 41939128](https://pubmed.ncbi.nlm.nih.gov/41939128/). *Ann Med Surg (Lond)*. [Epidemiology / Natural History]
Egbunah UP (2026). [PMID: 41729502](https://pubmed.ncbi.nlm.nih.gov/41729502/). *Natl Med J India*. [Epidemiology / Natural History]
Giraldo-Roldán D (2026). [PMID: 41712011](https://pubmed.ncbi.nlm.nih.gov/41712011/). *Head Neck Pathol*. [Diagnostic / Biomarker]
Sahay R (2026). [PMID: 41835778](https://pubmed.ncbi.nlm.nih.gov/41835778/). *Cureus*. [Case Report / Case Series]
Abbasi S (2026). [PMID: 41669697](https://pubmed.ncbi.nlm.nih.gov/41669697/). *Clin Case Rep*. [Case Report / Case Series]
Dang ZH (2026). [PMID: 41025462](https://pubmed.ncbi.nlm.nih.gov/41025462/). *Oral Dis*. [Epidemiology / Natural History]
Bologna-Molina R (2026). [PMID: 41054922](https://pubmed.ncbi.nlm.nih.gov/41054922/). *Histol Histopathol*. [Review / Meta-Analysis]
Chantarangsu S (2026). [PMID: 41338120](https://pubmed.ncbi.nlm.nih.gov/41338120/). *Int Dent J*. [Review / Meta-Analysis]
Hennocq Q (2026). [PMID: 41862322](https://pubmed.ncbi.nlm.nih.gov/41862322/). *Int J Oral Maxillofac Surg*. [Epidemiology / Natural History]
Ide F (2026). [PMID: 41672957](https://pubmed.ncbi.nlm.nih.gov/41672957/). *Oral Dis*. [Other]
AI-curated news mentioning ameloblastic carcinoma
Updated Aug 6, 2026
A study details the en bloc resection and dural reconstruction for secondary ameloblastic carcinoma with craniofacial and skull base invasion. This research contributes to the understanding of surgical approaches for this rare cancer type.